Eli Lilly has announced plans to expand its domestic medicine production in the US with four new pharmaceutical manufacturing ...

STOCKHOLM, SWEDEN / ACCESS Newswire / February 27, 2025 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) AlzeCure Pharma AB (publ) (FN STO:ALZCUR) today announced that its Year-end report for the period Januar ...

Lars Fruergaard Jørgensen might not be a household name, but his company’s drug Ozempic is. And its success has thrust him — ...

Eli Lilly will spend at least $27 billion dollars to build four manufacturing plants in the U.S. in order to move production back to America.

Eli Lilly and Company said Wednesday they plan to build new pharmaceutical manufacturing sites in the United States.

In a Chinese trial, trastuzumab rezetecan induced a 73% response rate in previously treated HER2-mutant non-small cell lung cancer (NSCLC). The safety profile of the novel antibody-drug conjugate was ...

Eli Lilly plans to invest $27 billion in four new pharmaceutical manufacturing facilities in the U.S., expanding its domestic production of medications across multiple therapeutic areas. The ...

Healthcare company stocks ended lower on a rough day for biotech companies and medical providers. Molina Healthcare and Centene notched big declines the day after a House budget resolution threatened ...

Secretary, Measles-dismisser, nepo-baby, bear cub-dumper, and vaccine skeptic, Robert F. Kennedy, Jr., was one of the ...

At a press conference in Washington, D.C., Eli Lilly And Co (NYSE:LLY) announced its plans to bolster its domestic medicine ...

Eli Lilly announces plans to build four new U.S. manufacturing facilities, enhancing domestic pharmaceutical production and creating jobs.

Eli Lilly said it plans to build three new plants in the U.S. to make the key ingredients used in pharmaceuticals, part of a ...